Translate:
AI driven preclinical disease modeling
Developing drug pipelines for Cardiovascular and Cardiometabolic disease
AI driven preclinical disease modeling
Developing drug pipelines for Cardiovascular and Cardiometabolic disease
EN
Translate:
Developing drug pipelines for Cardiovascular and Cardiometabolic disease
Developing drug pipelines for Cardiovascular and Cardiometabolic disease
Genome Biologics identifies viable drug candidates and FDA approved drug repositioning compounds for Cardiovascular and Cardiometabolic disease. Capitalising on the power of our patented Artificial Intelligence (AI) driven preclinical multi-modality drug testing technology - We leverage the power of AI-based machine learning with transformative single cell in vitro and in vivo transgenesis to dramatically reduce the cost, time, and ethical burden of preclinical research in the pharmaceutical industry.
Danziger Weg 17
61476 Kronberg im Taunus
Germany
Johnson & Johnson Innovation (JLABS)
Janssen Research Campus
Turnhoutseweg 30
B-2340 Belgium
Centre for Molecular Medicine
Goethe-University Frankfurt
Theodor-Stern-Kai 7
60590 Frankfurt am Main
Germany
Johnson & Johnson Innovation (JLABS)
Janssen Research Campus
Turnhoutseweg 30
B-2340 Belgium